search again

Ondansetron, Oral

Nationwide rates for HCPCS Q0162

Ondansetron 1 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$200%10%10th90th$0Professionalmedian $0 · 10th–90th $0$00%50%90th$0$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.98
Typical High
$22.39
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.05
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.03
Typical High
$0.06
BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.02
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.03
Typical High
$0.14
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.02
United
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.03
Typical High
$0.11
United
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$4.37
Typical High
$83.18